Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Shu Kawashima"'
Autor:
Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Tomoko Inoue, Hisato Shima, Jun Minakuchi, Shu Kawashima
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract Background Survival is equivalent between super high-flux hemodialysis (SHF-HD) and online hemodiafiltration (OHDF) with similar albumin leakage. According to the 2013 Japanese dialyzer performance classification, survival on HD is optimal w
Externí odkaz:
https://doaj.org/article/bd0dcc935c6543ed9f6b3fd2c163137e
Autor:
Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Tomoko Inoue, Hisato Shima, Jun Minakuchi, Shu Kawashima
Publikováno v:
Renal Replacement Therapy, Vol 8, Iss 1, Pp 1-14 (2022)
Abstract Background All-cause mortality is lower with a high substitution volume in predilution (pre) and postdilution (post) online hemodiafiltration (OHDF) than with hemodialysis (HD), and mortality does not significantly differ between pre- and po
Externí odkaz:
https://doaj.org/article/7a9b6f24e54e49229b2a293031a2c9c8
Autor:
Kazuyoshi Okada, Hiroyuki Michiwaki, Manabu Tashiro, Tomoko Inoue, Hisato Shima, Jun Minakuchi, Shu Kawashima
Publikováno v:
Renal Replacement Therapy, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background All-cause mortality can be reduced in patients receiving European-style high-volume post-dilution online hemodiafiltration (post-OHDF) compared with hemodialysis (HD). Japanese-style high-volume pre-dilution online hemodiafiltrati
Externí odkaz:
https://doaj.org/article/94da2ab06dad47a4be0dd3cb34817a5b
Autor:
Hisato Shima, Takuya Okamoto, Manabu Tashiro, Tomoko Inoue, Chiaki Masaki, Hiroaki Tada, Norimichi Takamatsu, Kazuhiko Kawahara, Kazuyoshi Okada, Toshio Doi, Jun Minakuchi, Shu Kawashima
Publikováno v:
Kidney Medicine, Vol 1, Iss 2, Pp 75-78 (2019)
Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-prov
Externí odkaz:
https://doaj.org/article/812ade80ddb94e60bf204ff243cafc50
Publikováno v:
BMC Research Notes, Vol 11, Iss 1, Pp 1-8 (2018)
Abstract Objective Sucroferric oxyhydroxide, a novel iron-based phosphate-binder, has been shown to have beneficial effects in lowering serum phosphorus levels and improving renal anemia in clinical studies. Although an effect of this agent on fibrob
Externí odkaz:
https://doaj.org/article/36ef3aec76284f449f3a605490df0e56
Autor:
Hisato Shima, Manabu Tashiro, Satoshi Yamada, Motokazu Matsuura, Kazuyoshi Okada, Toshio Doi, Jun Minakuchi, Shu Kawashima
Publikováno v:
BMC Nephrology, Vol 19, Iss 1, Pp 1-5 (2018)
Abstract Background Cilostazol is an antiplatelet drug that is widely prescribed for the prevention of secondary stroke. Adverse reactions to cilostazol include headaches, palpitations, and diarrhea. Little is known about the nephrotoxicity of cilost
Externí odkaz:
https://doaj.org/article/025276bb9f82456c88e8ddc6e3ecac82
Autor:
Kazuyoshi Okada, Manabu Tashiro, Maho Iwaki, Tomoko Inoue, Hisato Shima, Jun Minakuchi, Shu Kawashima
Publikováno v:
Nihon Toseki Igakkai Zasshi. 55:555-561
Autor:
Kazuyoshi Okada, Hiroyuki Michiwaki, Hiroaki Mori, Manabu Tashiro, Tomoko Inoue, Hisato Shima, Koji Ohshima, Jun Minakuchi, Shu Kawashima
Publikováno v:
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs.
Online hemodiafiltration (OHDF) for renal replacement therapy has two modes: pre- (pre-OHDF) and post-dilution OHDF (post-OHDF). To elucidate the precise differences between the two modes, a clinical study was performed using the same polysulfone hem
Autor:
Seiji Fukumoto, Munehide Matsuhisa, Akio Kuroda, Toshio Matsumoto, Shu Wakino, Yuichi Takashi, Keiko Miya, Hitoshi Minakuchi, Manabu Tashiro, Shu Kawashima, Kazuyoshi Okada, Hisato Shima, Jun Minakuchi, Masashi Ishizu
Publikováno v:
Journal of Bone and Mineral Metabolism. 38:70-77
Fibroblast growth factor (FGF) 23 is a bone-derived hormone regulating serum inorganic phosphate (Pi) concentration. FGF23 is also involved in the development of chronic kidney disease (CKD)-mineral and bone disorder. Serum FGF23 concentration begins
Autor:
Chiaki Masaki, Norimichi Takamatsu, Manabu Tashiro, Shu Kawashima, Kazuhiko Kawahara, Takuya Okamoto, Hiroaki Tada, Jun Minakuchi, Toshio Doi, Hisato Shima, Tomoko Inoue, Kazuyoshi Okada
Publikováno v:
Kidney Medicine, Vol 1, Iss 2, Pp 75-78 (2019)
Kidney Medicine
Kidney Medicine
Alogliptin is one of the dipeptidyl peptidase-4 inhibitors used to treat patients with type 2 diabetes. Little is known about the nephrotoxicity associated with alogliptin, such as nephrotic syndrome or interstitial nephritis. We report a biopsy-prov